Choline is increased in pre-lesional normal appearing white matter in multiple sclerosis
暂无分享,去创建一个
D. Arnold | N. De Stefano | S. Antel | M. Tartaglia | S. Narayanan | N. Stefano | S. Francis | Y. Lapierre | D. Arnold | S. Narayanan | R. Arnaoutelis | N. De Stefano | A. C. Santos | M. C. Tartaglia | R. Arnaoutelis | S. B. Antel | S. J. Francis | A. C. Santos | Y. Lapierre | D. L. Arnold | N. de Stefano | M. Tartaglia | Sridar Narayanan | Rozie Arnaoutelis | M. C. Tartaglia
[1] F. Barkhof,et al. Guidelines for the use of magnetic resonance techniques in monitoring the treatment of multiple sclerosis , 1996, Annals of neurology.
[2] P M Matthews,et al. Proton magnetic resonance spectroscopic imaging for metabolic characterization of demyelinating plaques , 1992, Annals of neurology.
[3] R. Rudick,et al. Axonal transection in the lesions of multiple sclerosis. , 1998, The New England journal of medicine.
[4] Jullie W Pan,et al. Evaluation of multiple sclerosis by 1H spectroscopic imaging at 4.1 T , 1996, Magnetic resonance in medicine.
[5] F Barkhof,et al. Neuronal damage in T1‐hypointense multiple sclerosis lesions demonstrated in vivo using proton magnetic resonance spectroscopy , 1999, Annals of neurology.
[6] D. Paty,et al. CORRELATION BETWEEN NMR SCAN AND BRAIN SLICE DATA IN MULTIPLE SCLEROSIS , 1984, The Lancet.
[7] S. Reingold,et al. The role of magnetic resonance techniques in understanding and managing multiple sclerosis. , 1998, Brain : a journal of neurology.
[8] T. Cloughesy,et al. Inverse correlation between choline magnetic resonance spectroscopy signal intensity and the apparent diffusion coefficient in human glioma , 1999, Magnetic resonance in medicine.
[9] G. Fein,et al. Biochemical alterations in multiple sclerosis lesions and normal‐appearing white matter detected by in vivo 31P and 1H spectroscopic imaging , 1994, Annals of neurology.
[10] Jia Newcombe,et al. High Resolution Proton NMR Spectroscopy of Multiple Sclerosis Lesions , 1995, Journal of neurochemistry.
[11] J S Wolinsky,et al. Serial proton magnetic resonance spectroscopic imaging, contrast‐enhanced magnetic resonance imaging, and quantitative lesion volumetry in multiple sclerosis , 1998, Annals of neurology.
[12] G. B. Pike,et al. Multiple sclerosis: magnetization transfer MR imaging of white matter before lesion appearance on T2-weighted images. , 2000, Radiology.
[13] P M Matthews,et al. Proton magnetic resonance spectroscopy for metabolic characterization of plaques in multiple sclerosis , 1991, Neurology.
[14] W. Hickey. Migration of Hematogenous Cells Through the Blood‐Brain Barrier and the Initiation of CNS Inflammation , 1991, Brain pathology.
[15] M W Weiner,et al. 1H MRSI of normal appearing white matter in multiple sclerosis , 1997, Multiple sclerosis.
[16] M W Weiner,et al. A serial study of new MS lesions and the white matter from which they arise , 1998, Neurology.
[17] J. Coyle,et al. Immunocytochemical localization of N-acetyl-aspartate with monoclonal antibodies , 1991, Neuroscience.
[18] B. Scheithauer,et al. Ultrastructure of multiple sclerosis. , 1994, Ultrastructural pathology.
[19] G J Barker,et al. The proton NMR spectrum in acute EAE: The significance of the change in the Cho:Cr ratio , 1993, Magnetic resonance in medicine.
[20] R. Tarducci,et al. Absolute quantification of brain metabolites by proton magnetic resonance spectroscopy in normal-appearing white matter of multiple sclerosis patients. , 1999, Brain : a journal of neurology.
[21] T. Richards. Proton MR spectroscopy in multiple sclerosis: value in establishing diagnosis, monitoring progression, and evaluating therapy. , 1991, AJR. American journal of roentgenology.
[22] Paul M. Matthews,et al. Magnetic resonance spectroscopy of multiple sclerosis: imaging axonal damage , 2001 .
[23] A Heerschap,et al. Common processing of in vivo MR spectra , 2001, NMR in biomedicine.
[24] R. P. Mansfield,et al. Volume Selection Using Gradients and Selective Pulses , 1987, Annals of the New York Academy of Sciences.
[25] P M Matthews,et al. Proton magnetic resonance spectroscopy of human brain in vivo in the evaluation of multiple sclerosis: Assessment of the load of disease , 1990, Magnetic resonance in medicine.
[26] D J Jenden,et al. In vivo 1H MRS choline: correlation with in vitro chemistry/histology. , 1996, Life sciences.
[27] Moses Rodriguez,et al. Distinct Patterns of Multiple Sclerosis Pathology Indicates Heterogeneity in Pathogenesis , 1996, Brain pathology.
[28] M Filippi,et al. Magnetization transfer changes in the normal appering white matter precede the appearance of enhancing lesions in patients with multiple sclerosis , 1998, Annals of neurology.